The protective effect of hypervolemic hemodilution in experimental heatstroke.
The authors tested the hypothesis in a rat model that hypervolemic hemodilution during heatstroke affected the mean arterial pressure (MAP), striatal dopamine (DA) release, and local cerebral blood flow and neuronal damage score in different brain structures. The heatstroke was induced by exposing the urethane-anesthetized rats to an ambient temperature of 42 degrees C. Hypervolemic hemodilution was produced by intravenous administration of 10% human albumin. Relative and absolute blood flow in the corpus striatum were determined using the laser Doppler flowmetry and the autoradiography diffusible tracer technique, respectively. The DA release in the striatum was estimated using the in vivo microdialysis technique. After onset of heatstroke, animals with hypervolemic state alone, produced by saline or heparinized blood injection, displayed higher values of DA release, as well as neuronal damage score in the striatum, hypothalamus, or cortex, but lower values of MAP and blood flow in the striatum, hypothalamus, or cortex compared to normothermic controls. However, the heatstroke-induced arterial hypotension, cerebral ischemia, increased striatal DA overload, and increased neuronal damage score were attenuated by induction of both hypervolemic and hemodilution state with 10% albumin either before or after the onset of heatstroke. In addition, constant infusions of a vasopressor agent phenylephrine (2 microg kg(-1) min(-1)) after the onset of heatstroke failed to maintain appropriate levels of MAP and resulted in no protection against heatstroke. Thus, it appears that the observed benefit of the 10% albumin is secondary to hemodilution and/or maintenance of MAP.
Chang
C K
CK
Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan.
Chien
C H
CH
Chou
H L
HL
Lin
M T
MT
D000704:Analysis of Variance; D000818:Animals; D001831:Body Temperature; D002245:Carbon Dioxide / Q000097:blood; D003342:Corpus Striatum / Q000098:blood supply / Q000473:pathology; D004195:Disease Models, Animal; D006220:Haloperidol / Q000627:therapeutic use; D018883:Heat Stroke / Q000097:blood / Q000503:physiopathology* / Q000517:prevention & control; D006438:Hemodilution; D008991:Monitoring, Physiologic; D009474:Neurons / Q000473:pathology; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D051381:Rats; D017208:Rats, Wistar; D012039:Regional Blood Flow; D015996:Survival Rate; D013997:Time Factors
D002245:Carbon Dioxide; D006220:Haloperidol; D010100:Oxygen